Accessibility Menu
Intuitive Surgical logo

Intuitive Surgical(NASDAQ) ISRG

Current Price$337.33
Market Cap$119.23BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2000)+16,717%
5 Year+4%
1 Year-31%
1 Month-16%
Intuitive Surgical last closing stock price
MetricPriceDate
Last closeUSD 337.502026-07-24
Intuitive Surgical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.29%USD 345.422026-07-17
1 month-16.01%USD 401.832026-06-24
3 month-30.01%USD 482.222026-04-24
Year to date-40.41%USD 566.362025-12-31
1 year-30.93%USD 488.612025-07-24
3 year+1.99%USD 330.902023-07-25
5 year+3.69%USD 325.492021-07-23
Since inception+16,716.61%USD 2.012000-06-13

Intuitive Surgical Financials at a Glance

Market Cap

$119.23BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$11.03B

Net Income (TTM)

$3.14B

EPS (TTM)

$8.73

P/E Ratio

38.68

Dividend

$0.00

Beta (Volatility)

1.27 (Average)

Price

$337.33

Volume

123,951

Open

$334.74

Previous Close

$337.33

Daily Range

$332.38 - $341.78

52-Week Range

$328.57 - $603.88

Estimated Earnings Date

Oct 20, 2026

ISRG: Motley Fool Moneyball Superscore

83

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Intuitive Surgical

Intuitive Surgical makes robotic systems that help doctors perform less invasive surgeries. Its da Vinci and Ion systems allow for smaller incisions and faster recovery for patients. Hospitals use these tools to improve surgical precision and patient outcomes.

Robots in the Operating Room: What’s on Offer?

  • da Vinci Surgical Systems: Robotic platforms for minimally invasive surgery in hospitals and clinics.
  • Instruments & Accessories (61% of revenue): Surgical tools, staplers, and energy devices used with da Vinci and Ion systems.
  • Ion Endoluminal System: Robotic platform for minimally invasive lung biopsies, mainly for pulmonologists.
  • Services (16% of revenue): Installation, repair, maintenance, and technical support for hospitals and clinics.
  • Digital Solutions: Data analytics, 3D imaging, and training tools for surgical teams and hospital administrators.

Growth Spurts and Global Moves

  • Launched da Vinci 5 system in 2024, expanding the product line.
  • Expanded Ion system placements by 27% in 2024.
  • Manufactured products at existing sites in the US and Mexico, and planned a new facility in Bulgaria in 2024.
  • Entered China through a joint venture with Shanghai Fosun Pharma.
  • Invested in digital solutions and new technologies through Intuitive Ventures Fund I and II.

What Makes Intuitive Surgical Stand Out?

Intuitive Surgical connects robotic systems, digital tools, and services into a single ecosystem for hospitals worldwide. Its global installed base and regulatory approvals in major markets support broad adoption. The company’s focus on training and analytics helps hospitals use its technology more effectively.

Five Things You Need to Know

  • Revenue was $8.35 billion in 2024, up 17% from 2023.
  • Instruments and accessories made up 61% of 2024 revenue.
  • Operating income was $2.35 billion in 2024, up 33% year-on-year.
  • International sales were 33% of total revenue in 2024.

Bottom Line

Intuitive Surgical has grown by expanding its robotic platforms and digital services. Its focus on minimally invasive care and global reach positions it as a key player in surgical technology.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Employees

17,021

CEO

Dave Rosa Rosa

Headquarters

Sunnyvale, CA 94086-5304, US

ISRG Financials

Key Financial Metrics (TTM)

Gross Margin

66.68%

Operating Margin

31.28%

Net Income Margin

28.45%

Return on Equity

17.83%

Return on Capital

16.25%

Return on Assets

15.04%

Earnings Yield

2.59%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$119.23BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

353.28M

Volume

123.95K

Avg. Volume

2.88M

Financials (TTM)

Gross Profit

$7.36B

Operating Income

$3.45B

EBITDA

$4.51B

Operating Cash Flow

$3.71B

Capital Expenditure

-$483.80M

Free Cash Flow

$3.22B

Cash & ST Invst.

$5.22B

Total Debt

$0.00

Intuitive Surgical Performance Analysis

Intuitive Surgical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 6,222,200,0009.0%
20232023-12-31USD 7,124,100,00014.5%
20242024-12-31USD 8,352,100,00017.2%
20252025-12-31USD 10,064,700,00020.5%
Intuitive Surgical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-302.7%
Q42025-12-3114.4%
Q12026-03-31-3.3%
Q22026-06-304.4%
Intuitive Surgical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 3.65-21.6%
20232023-12-31USD 5.0337.7%
20242024-12-31USD 6.4227.5%
20252025-12-31USD 7.8722.7%
Intuitive Surgical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-307.7%
Q42025-12-3113.3%
Q12026-03-313.2%
Q22026-06-303.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$2.89B

+18.5%

Gross Profit

$1.96B

+21.2%

Gross Margin

67.78%

N/A

Market Cap

$119.23BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$7.00M

N/A

Employees

17,021

N/A

Net Income

$818.10M

+24.3%

EBITDA

$1.17B

+18.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$5.22B

-2.1%

Total Debt

$0.00

N/A

Accounts Receivable

$1.67B

+20.0%

Inventory

$2.03B

+21.7%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

15.04%

N/A

Return on Invested Capital

18.21%

N/A

Free Cash Flow

$948.40M

+69.3%

Operating Cash Flow

$1.06B

+48.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BDXBecton, Dickinson and Company
$156.36+2.22%
RMDResMed Inc.
$195.27+1.76%
WSTWest Pharmaceutical Services, Inc.
$328.20-7.67%
HOLXHologic, Inc.
$76.01+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
SOFISoFi Technologies
$16.46-0.01%

Questions About ISRG

What is the current price of Intuitive Surgical?

Intuitive Surgical is trading at $337.33 per share.

What is the 52-week range for Intuitive Surgical?

Over the past 52 weeks, Intuitive Surgical has traded between $328.57 and $603.88.

How much debt does Intuitive Surgical have?

As of the most recent reporting period, Intuitive Surgical reported total debt of $0.00.

How much cash does Intuitive Surgical have on hand?

Intuitive Surgical reported $2.79B in cash and cash equivalents in its most recent financial results.

What is Intuitive Surgical’s dividend yield?

Intuitive Surgical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.